Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
Briefing on Geographical Access to Head and Neck Cancer Clinical Trials
FDA Grants Priority Review to Zongertinib for HER2-Mutated NSCLC
New Insights From IDEA-France & HORG: The Prognostic Power of ctDNA and Immunoscore